APA (7th ed.) Citation

Leah E Cahill, Rachel A Warren, Gideon D Bahn, Allie S Carew, Andrew P Levy, John Sapp, . . . Peter Reaven. (2024). Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial. Elsevier.

Chicago Style (17th ed.) Citation

Leah E Cahill, Rachel A Warren, Gideon D Bahn, Allie S Carew, Andrew P Levy, John Sapp, Eric B Rimm, and Peter Reaven. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People with Type Two Diabetes: The Veterans Affairs Diabetes Trial. Elsevier, 2024.

MLA (9th ed.) Citation

Leah E Cahill, et al. Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People with Type Two Diabetes: The Veterans Affairs Diabetes Trial. Elsevier, 2024.